Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-18-012150

Options or other derivatives

  • President & CEO acquired 1,014,310 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Stewart Robert A President & CEO 2018-05-07 Grant or award · Stock Option +681,199 681,199 D
Stewart Robert A President & CEO 2018-05-07 Grant or award · Restricted Stock Units +333,111 333,111 D
Loading xslF345X03/doc4.xml…